Fresh off the announcement of its first acquisition, Seattle’s Social Housing Developer has opened its lottery for ...
7d
Trump said he'd 'remember' companies that didn't apply for tariff refunds. Many of them are anyway
Walmart confirmed to CNBC it has sought a tariff refund and plans to use any money it receives back to invest in lower prices ...
Backed by the phase 2b/3 EPICS-III trial, saroglitazar demonstrated a significant 56.7% biochemical response rate compared with 9.8% for placebo, while showing favorable safety data.
The combination regimen significantly improved progression-free survival and objective response rates in patients who were intolerant to or failed prior imatinib therapy ...
Dow unveils DOWSIL TC-3120 thermal gel for AI data centers and 800G/1.6T optics, boosting thermal management reliability—see why it matters now.
Target's Prat Vemana shares how design, AI and a model-agnostic platform are powering the retailer's next chapter.
Critics have labelled the compensation program a "slush fund" for Trump allies, but officials insist anyone can apply.
Standard Chartered analysts argued in a note that Ethereum’s current price doesn’t reflect its network's improving metrics.
NDA acceptance with Priority Review builds upon previous assignment of Breakthrough Therapy Designation and Real-Time ...
Federal immigration courts are working to speed up deportations, reportedly by holding mass hearings with potentially ...
Target may have the most loyal shoppers of any big box department store chain. Enthusiasts often talk about how they go to ...
FDA-approved EB therapies expand options for gene replacement and wound healing, but success depends on careful wound preparation and timing, experts say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results